American Society of Nephrology (ASN) Kidney Week 2021
We unite science, talent, and technology to get ahead of disease together.
We prevent and treat disease with vaccines, specialty, and general medicines. We focus on science of the immune system, human genetics, and advanced technologies investing in four core therapeutic areas and future opportunities to impact health at scale. We operate responsibly for all our stakeholders by prioritising Innovation, Performance, and Trust.
At this year’s virtual ASN Kidney Week, we are proud to share eight data presentations from across our growing pipeline and portfolio of Specialty medicines, underscoring our commitment to drive innovation for people with kidney disease.
Notably, we are pleased to share new data from the Phase 3 ASCEND programme evaluating an investigational medicine for the treatment of patients with anaemia due to chronic kidney disease, derived from Nobel Prize winning science.
[Targeting the HIF pathway] is modulating a natural system that operates within the body to maintain your blood haemoglobin at a proper level, and which fails in kidney disease. So it is an attempt to intervene in the natural system.
Our Kidney Week presentations
More information about GSK
We are a science-led global healthcare company with a special purpose to improve the quality of human life.
Research and development
Science can improve health and well-being in so many ways, from the development of everyday healthcare products to medicines and vaccines.